First, please correct me if I'm wrong, but is it possible that the article made a mistake either in the dosages or the substance that was administered? It calls 5mg/kg of psilocybin a low dose. To me, this is an insanely high amount if we're really talking pure psilocybin (not psilocybin mushrooms). Johns Hopkins reported treating people with (high) therapeutic doses of psilocybin (not mushrooms) of between 20mg and 30mg per 70kg. In strictly mushroom weight, that's anything between 3g and 5g of dried cubensis. If the article is correct, what they administer those mice is the equivalent of giving a 70kg human 350mg of psilocybin (as a low dose lol), or about 50g-60g of dried mushrooms to munch on? I hope the article made a mistake, rather than someone from the research team misread the recommended dosage.
EDIT: According to my limited search, a 12-weeks old lab rat could weight anything between 0.25-0.5kg. At 5mg-15mg/kg, that's approximately 1.25-2.50mg for low doses of psilocybin and 3.75-7.5mg for high doses. I don't find this as outrageous as originally. It could work if we take into consideration that brain size is probably a more significant factor than body mass.
Second.
> this study suggests that psilocybin impacts multiple hallmarks of aging by reducing oxidative stress, improving DNA repair responses, and preserving telomere length. Telomeres are the structured ends of a chromosome, protecting it from damage that could lead to the formation of age-related diseases, such as cancer, neurodegeneration or cardiovascular disease. These foundational processes influence human aging and the onset of these chronic diseases.
Unless I misunderstand what I'm reading, I wouldn't say that it's really psilocybin (the chemical) that's responsible. It's the taking then subsequent tripping. It's now known that without the trip, no benefit. If my intuition is correct, it could be that LSD along with a few other psychedelics (and associated practices) might affect you in a similar way over the long run.